Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
18
GLYC Quote, Financials, Valuation and Earnings
Last price:
$0.23
Seasonality move
:
-6.72%
Day range:
$0.20 - $0.25
52-week range:
$0.14 - $3.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.32x
Volume:
1M
Avg. volume:
1.3M
1-year change:
-88.6%
Market cap:
$15.1M
Revenue:
$10K
EPS (TTM):
-$0.62
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $10.2M | $1.2M | $75K | $10K | |
| Revenue Growth (YoY) | -- | -- | -88.59% | -93.53% | -86.67% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $47M | $44.9M | $47.5M | $28.4M | $20.1M | |
| Selling, General & Admin | $14.4M | $16.7M | $17.1M | $19.1M | $19.2M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $61.4M | $61.7M | $64.6M | $47.5M | $39.3M | |
| Operating Income | -$61.4M | -$51.5M | -$63.4M | -$47.4M | -$39.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$57.9M | -$51M | -$63.4M | -$46.7M | -$36.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$57.9M | -$51M | -$63.4M | -$46.7M | -$36.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$57.9M | -$51M | -$63.4M | -$46.7M | -$36.9M | |
| Basic EPS (Cont. Ops) | -$1.34 | -$1.12 | -$1.23 | -$0.89 | -$0.58 | |
| Diluted EPS (Cont. Ops) | -$1.34 | -$1.12 | -$1.23 | -$0.89 | -$0.58 | |
| Weighted Average Basic Share | $43.3M | $45.7M | $51.5M | $52.5M | $63.3M | |
| Weighted Average Diluted Share | $43.3M | $45.7M | $51.5M | $52.5M | $63.3M | |
| EBITDA | -$61.1M | -$51.2M | -$63.2M | -$47.2M | -$39.1M | |
| EBIT | -$61.4M | -$51.5M | -$63.4M | -$47.4M | -$39.3M | |
| Revenue (Reported) | -- | $10.2M | $1.2M | $75K | $10K | |
| Operating Income (Reported) | -$61.4M | -$51.5M | -$63.4M | -$47.4M | -$39.3M | |
| Operating Income (Adjusted) | -$61.4M | -$51.5M | -$63.4M | -$47.4M | -$39.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1M | $86.6K | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -91.34% | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $10.7M | $13.3M | $4.9M | $5.3M | $1.7M | |
| Selling, General & Admin | $4.1M | $4.1M | $3.8M | $4.5M | $4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$4.3M | |
| Operating Expenses | $14.7M | $17.4M | $8.8M | $9.8M | $5.7M | |
| Operating Income | -$13.7M | -$17.3M | -$8.8M | -$9.8M | -$5.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$13.7M | -$17.3M | -$8.5M | -$9.2M | -$9.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$13.7M | -$17.3M | -$8.5M | -$9.2M | -$9.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$13.7M | -$17.3M | -$8.5M | -$9.2M | -$9.8M | |
| Basic EPS (Cont. Ops) | -$0.29 | -$0.34 | -$0.16 | -$0.14 | -$0.15 | |
| Diluted EPS (Cont. Ops) | -$0.29 | -$0.34 | -$0.16 | -$0.14 | -$0.15 | |
| Weighted Average Basic Share | $47.5M | $51.6M | $52.4M | $64.3M | $64.5M | |
| Weighted Average Diluted Share | $47.5M | $51.6M | $52.4M | $64.3M | $64.5M | |
| EBITDA | -$13.7M | -$17.3M | -$8.7M | -$9.8M | -$5.7M | |
| EBIT | -$13.7M | -$17.3M | -$8.8M | -$9.8M | -$5.7M | |
| Revenue (Reported) | $1M | $86.6K | -- | -- | -- | |
| Operating Income (Reported) | -$13.7M | -$17.3M | -$8.8M | -$9.8M | -$5.7M | |
| Operating Income (Adjusted) | -$13.7M | -$17.3M | -$8.8M | -$9.8M | -$5.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $1.3M | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $44.7M | $46.3M | $35.4M | $20.7M | $19.3M | |
| Selling, General & Admin | $16.6M | $16.6M | $18.9M | $19.6M | $17.5M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$4.3M | |
| Operating Expenses | $61.3M | $62.9M | $54.3M | $40.3M | $36.8M | |
| Operating Income | -$51.3M | -$61.6M | -$54.2M | -$40.3M | -$36.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$50.2M | -$61.6M | -$53.9M | -$38.1M | -$39.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$50.2M | -$61.6M | -$53.9M | -$38.1M | -$39.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$50.2M | -$61.6M | -$53.9M | -$38.1M | -$39.7M | |
| Basic EPS (Cont. Ops) | -$1.13 | -$1.22 | -$1.02 | -$0.63 | -$0.62 | |
| Diluted EPS (Cont. Ops) | -$1.13 | -$1.22 | -$1.02 | -$0.63 | -$0.62 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$51M | -$61.3M | -$54M | -$40.1M | -$36.7M | |
| EBIT | -$51.3M | -$61.6M | -$54.2M | -$40.3M | -$36.8M | |
| Revenue (Reported) | -- | $1.3M | -- | -- | -- | |
| Operating Income (Reported) | -$51.3M | -$61.6M | -$54.2M | -$40.3M | -$36.8M | |
| Operating Income (Adjusted) | -$51.3M | -$61.6M | -$54.2M | -$40.3M | -$36.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $10M | $1.1M | $75K | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $33.2M | $34.6M | $22.5M | $14.8M | $14M | |
| Selling, General & Admin | $12.7M | $12.6M | $14.4M | $14.9M | $13.2M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$4.3M | |
| Operating Expenses | $45.9M | $47.2M | $36.9M | $29.7M | $27.2M | |
| Operating Income | -$35.9M | -$46M | -$36.8M | -$29.7M | -$27.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$35.5M | -$46M | -$36.4M | -$27.8M | -$30.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$35.5M | -$46M | -$36.4M | -$27.8M | -$30.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$35.5M | -$46M | -$36.4M | -$27.8M | -$30.7M | |
| Basic EPS (Cont. Ops) | -$0.79 | -$0.90 | -$0.69 | -$0.44 | -$0.48 | |
| Diluted EPS (Cont. Ops) | -$0.79 | -$0.90 | -$0.69 | -$0.44 | -$0.48 | |
| Weighted Average Basic Share | $134.9M | $153.8M | $157.2M | $189M | $193.4M | |
| Weighted Average Diluted Share | $134.9M | $153.8M | $157.2M | $189M | $193.4M | |
| EBITDA | -$35.7M | -$45.8M | -$36.6M | -$29.6M | -$27.2M | |
| EBIT | -$35.9M | -$46M | -$36.8M | -$29.7M | -$27.2M | |
| Revenue (Reported) | $10M | $1.1M | $75K | -- | -- | |
| Operating Income (Reported) | -$35.9M | -$46M | -$36.8M | -$29.7M | -$27.2M | |
| Operating Income (Adjusted) | -$35.9M | -$46M | -$36.8M | -$29.7M | -$27.2M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $158.2M | $137M | $90.3M | $47.9M | $41.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $4.1M | $1.2M | $532.5K | $2.7M | $1.8M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $162.5M | $138.3M | $90.8M | $50.7M | $43.8M | |
| Property Plant And Equipment | $3.8M | $2.9M | $1.9M | $751.2K | $767.8K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | $294.7K | $154.2K | |
| Total Assets | $168M | $142.8M | $94.3M | $51.8M | $45.3M | |
| Accounts Payable | $1.4M | $2.1M | $2.1M | $970.2K | $868.1K | |
| Accrued Expenses | $5.7M | $5.5M | $6.2M | $4M | $2.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $804.1K | $898.6K | $1M | $918.6K | $741.6K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $11M | $12.4M | $11.8M | $8.9M | $6.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $13.8M | $14.6M | $12.7M | $8.9M | $6.9M | |
| Common Stock | $43.5K | $49K | $52.3K | $54.4K | $64.4K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $154.2M | $128.2M | $81.6M | $42.9M | $38.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $154.2M | $128.2M | $81.6M | $42.9M | $38.4M | |
| Total Liabilities and Equity | $168M | $142.8M | $94.3M | $51.8M | $45.3M | |
| Cash and Short Terms | $158.2M | $137M | $90.3M | $47.9M | $41.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $142.9M | $101.9M | $51.6M | $49.4M | $14.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $2.8M | $2.2M | $2.1M | $2.4M | $1.2M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $145.6M | $104.1M | $53.8M | $52M | $15.6M | |
| Property Plant And Equipment | $3.2M | $2.2M | $1.3M | $1.1M | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | $52.3K | |
| Total Assets | $150.4M | $107.9M | $56M | $53.2M | $15.7M | |
| Accounts Payable | $1.1M | $1.4M | $852.1K | $329.9K | $581.8K | |
| Accrued Expenses | $4.8M | $5M | $3.7M | $2.9M | $1.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $874.2K | $974.8K | $1.1M | $749.6K | $262.1K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $9.8M | $9.7M | $7.7M | $6.4M | $4.3M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $12.2M | $11.4M | $7.8M | $6.7M | $4.3M | |
| Common Stock | $47.8K | $51.7K | $52.4K | $64.4K | $64.5K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $138.3M | $96.6M | $48.1M | $46.5M | $11.4M | |
| Total Liabilities and Equity | $150.4M | $107.9M | $56M | $53.2M | $15.7M | |
| Cash and Short Terms | $142.9M | $101.9M | $51.6M | $49.4M | $14.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$57.9M | -$51M | -$63.4M | -$46.7M | -$36.9M | |
| Depreciation & Amoritzation | $279.2K | $270.8K | $264.6K | $207.2K | $153.3K | |
| Stock-Based Compensation | $6.2M | $6.9M | $6.1M | $3.9M | $3.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$52M | -$39.2M | -$57.5M | -$46.5M | -$34.9M | |
| Capital Expenditures | $144.9K | $68.5K | $14.9K | $84.2K | $21.4K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$144.9K | -$68.5K | -$14.9K | -$84.2K | -$21.4K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $412.9K | $18.1M | $10.7M | $4.2M | $28.8M | |
| Beginning Cash (CF) | $209.9M | $158.2M | $137M | $90.3M | $47.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$51.7M | -$21.2M | -$46.8M | -$42.4M | -$6.1M | |
| Ending Cash (CF) | $158.2M | $137M | $90.3M | $47.9M | $41.8M | |
| Levered Free Cash Flow | -$52.1M | -$39.3M | -$57.5M | -$46.5M | -$34.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$13.7M | -$17.3M | -$8.5M | -$9.2M | -$9.8M | |
| Depreciation & Amoritzation | $66.5K | $67.4K | $47.4K | $42.8K | $8.1K | |
| Stock-Based Compensation | $1.7M | $1.6M | $914K | $887.8K | $1.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$11.5M | -$16.9M | -$8.6M | -$8.7M | -$8M | |
| Capital Expenditures | $15.8K | $4.3K | $2.5K | $7.9K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$15.8K | -$4.3K | -$2.5K | -$7.9K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $4.5M | $20.8K | -- | $61.6K | -- | |
| Beginning Cash (CF) | $149.8M | $118.9M | $60.2M | $58M | $22.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$7M | -$16.9M | -$8.6M | -$8.6M | -$8M | |
| Ending Cash (CF) | $142.9M | $101.9M | $51.6M | $49.4M | $14.4M | |
| Levered Free Cash Flow | -$11.5M | -$17M | -$8.6M | -$8.7M | -$8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$50.2M | -$61.6M | -$53.9M | -$38.1M | -$39.7M | |
| Depreciation & Amoritzation | $270.2K | $271.3K | $223.1K | $175.7K | $58.5K | |
| Stock-Based Compensation | $7M | $6.4M | $4.3M | $3.5M | $4.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$42.3M | -$54.4M | -$51.4M | -$35.2M | -$35M | |
| Capital Expenditures | $42.7K | $50.7K | $86.6K | $20.6K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$42.7K | -$50.7K | -$86.6K | -$20.6K | -$10.8K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $14.4M | $13.5M | $1.1M | $33M | $6.4K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$28M | -$40.9M | -$50.3M | -$2.2M | -$35M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$42.4M | -$54.4M | -$51.4M | -$35.2M | -$35M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$35.5M | -$46M | -$36.4M | -$27.8M | -$30.7M | |
| Depreciation & Amoritzation | $202.4K | $203K | $161.4K | $130K | $35.2K | |
| Stock-Based Compensation | $5.3M | $4.8M | $3M | $2.6M | $3.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$29.6M | -$44.7M | -$38.5M | -$27.3M | -$27.4M | |
| Capital Expenditures | $30.3K | $12.5K | $84.2K | $20.6K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$30.3K | -$12.5K | -$84.2K | -$20.6K | -$10K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $14.3M | $9.6M | -- | $28.8M | $5.4K | |
| Beginning Cash (CF) | $462.9M | $388.4M | $227M | $170.9M | $95.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$15.3M | -$35.1M | -$38.6M | $1.5M | -$27.4M | |
| Ending Cash (CF) | $447.5M | $353.2M | $188.4M | $172.4M | $68.1M | |
| Levered Free Cash Flow | -$29.6M | -$44.7M | -$38.6M | -$27.3M | -$27.4M | |
Get GLYC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GLYC
Sector
P/E ratio
--
25.86x
PEG ratio
--
0.00x
P/B ratio
1.32x
1.85x
Price / LTM sales
--
1.86x
Growth Metrics
GLYC
Sector
Revenue growth
--
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
--
8.73%
Earnings forecast
-$0.15
-$0.20
Profitability
GLYC
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
--
-14.06%
Return on assets
--
-11.77%
Return on equity
--
-14.78%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Mar
27
Estimated Next Earnings Date
Feb
12
Balance Sheet
GLYC
Sector
Total cash
$14.4M
$47M
Short term investments
--
$45.2M
Total assets
$45.3M
$142.6M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
